📑Produkty lecznicze.
Procurement process summary
This process is to purchase Produkty lecznicze.
This contract was awarded by 🇪🇺 Wojewódzki Szpital Zespolony for an amount of PLN 27,000 to 1 supplier. It was published on 2013-12-31 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇪🇺 Wojewódzki Szpital Zespolony Buying unitnot reported Publication date2013-12-31 Contest statusnot reported DescriptionRozne produkty lecznicze.Awards
This award was granted to Interforum Pharma Sp. z o.o. by Wojewódzki Szpital Zespolony for an amount of PLN 27,000. The procurement process was conducted through open for the category of goods. The award was granted on 2014-02-21. This is award number 2.
This contract has multiple awards. This is award number 2. View other awards for this contract
| Supplier | Amount | Award date | Award number |
|---|---|---|---|
| 🇵🇱 Interforum Pharma Sp. z o.o. | PLN 27,000 | 2014-02-21 | 2 |
Market context and opportunities
The execution of this contract allows the entity Wojewódzki Szpital Zespolony to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberEU_ocds-70d2nz-8567e3a0-44fc-4792-bada-a08d110453fa-award-2Publication date2013-12-31Contract datenot reportedAward date2014-02-21CategoriesgoodsPurchase modalityopenMethod detailspt_openStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
